메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

진선경 (경희대학교, 경희대학교 대학원)

지도교수
남혜정
발행연도
2023
저작권
경희대학교 논문은 저작권에 의해 보호받습니다.

이용수7

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (3)

초록· 키워드

오류제보하기
Background
This study used a network pharmacology approach to explore the active compounds and therapeutic mechanisms of Yijin-tang on Meniere''s disease.

Methods
The active compounds of Yijin-tang were screened via the TCMSP database and their target proteins were screened via the STITCH database. The GeneCard was used to establish the Meniere''s disease-related genes. The intersection targets were obtained through Venny2.1.0. The related protein interaction network was constructed with the STRING database, and topology analysis was performed through CytoNCA. GO biological function analysis and KEGG enrichment analysis for core targets were performed through the ClueGO.

Results
Network analysis identified 126 compounds in five herbal medicines of Yijin-tang. Among them, 15 compounds(naringenin, beta-sitosterol, Stigmasterol, baicalein, Baicalin, Calycosin, Dihydrocapsaicin, formononetin, Glabridin, isorhamnetin, kaempferol, Mairin, quercetin, sitosterol, nobiletin) were the key chemicals. The target proteins were 119, and 7 proteins(TNF, CASP9, PARP1, CCL2, CFTR, NOS2, NOS1) were linked to Meniere''s disease-related genes. Core genes in this network were TNF, CASP9, and NOS2. GO/KEGG pathway analysis results indicate that these targets are primarily involved in regulating biological processes, such as such as excitotoxicity, oxidative stress, and apoptosis.

Conclusion
Pharmacological network analysis can help to explain the applicability of Yijin-tang on Meniere''s disease.

목차

Ⅰ. 서론 ··················································································································· 1
Ⅱ. 연구 방법 ·········································································································· 3
1. 이진탕의 활성 성분 수집 ············································································· 4
2. 이진탕의 활성 성분의 타겟 단백질 수집 ······················································ 5
3. 메니에르병 연관 단백질 수집 ······································································ 6
4. 교차 타겟 단백질 확인 ················································································ 6
5. Protein-Protein Interaction(PPI) 및 Core Genes 분석 ·································· 7
6. Gene Ontology(GO) 및 Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway 분석 ····························································································· 9
Ⅲ. 결과 ················································································································· 10
1. 이진탕의 활성 성분 및 타겟 단백질 ·························································· 10
2. 메니에르병 연관 단백질 ············································································ 14
3. 단백질 표적 간 교차 분석 ········································································· 15
4. Protein-Protein Interaction(PPI) network 분석 및 Core Genes 추출 ···················································································································· 16
5. Gene Ontology(GO) 및 Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway 분석 ··························································································· 18
Ⅳ. 고찰 ················································································································· 21
Ⅴ. 결론 ················································································································· 34
참고문헌 ················································································································ 35
부록 ······················································································································· 53
Abstract ················································································································ 64

최근 본 자료

전체보기

댓글(0)

0